BRUKER CORP
No SEC Form 4 filings for $BRKR in the last 30 days.
See all $BRKR insider activity →Bruker (BRKR) reported Q2 sales of $838.5M and a net loss of $52M. It cut 2026 revenue guidance to $3.54B-$3.57B and recorded $134.9M in goodwill and intangible impairments. Bruker expanded its AI lab collaboration with Atinary, including a minority stake, to build AI-driven Self-Driving Labs using Chemspeed, FT-NMR and SciY software.
Bruker Corporation (BRKR) said its board declared a quarterly cash dividend of $0.05 per common share ($0.01 par). The dividend was declared Aug. 14, 2026, with a record date of Sept. 21, 2026 and a payment date of Oct. 7, 2026, for shareholders of record then.
Bruker (BRKR) reported Q2 2026 revenue of $838.5 million, up 5.2% year over year, with organic growth of 2.8% (3.4% excluding U.S. tariff refund impacts). Non-GAAP gross margin was 52.1% and non-GAAP EPS $0.49. FY2026 guidance: revenue $3.54B to $3.57B and non-GAAP EPS $2.10 to $2.15.
Over the past 7 days, alphai's AI scored 6 news stories mentioning BRKR (BRUKER CORP). Coverage has skewed bullish: 2 bullish, 3 neutral, and 1 bearish.
Recent BRKR coverage spans earnings, market movers and corporate actions.
Guidance trim plus a deeper AI automation partnership is a mixed signal for near-term demand but supportive for longer-term recurring revenue potential.
The dividend declaration is a shareholder-return update that can modestly support income-focused sentiment, but it is not a fundamental earnings or guidance change.
The call provides fresh, decision-relevant guidance and segment demand signals (semiconductor metrology, energy research) that can drive near-term estimate revisions.
The deal is a strategic partnership plus minority investment, likely supportive for Bruker’s lab-automation and AI-driven R&D positioning, but without disclosed financial terms.
The article centers on Bruker’s Q2 miss, guidance trim, and management’s explanation for revenue timing and margin path, which can drive near-term positioning.
alphai scores every news story that mentions BRKR with an AI model for sentiment and relevance, and aggregates insider trades from BRUKER CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Bruker (BRKR) reported Q2 sales of $838.5M and a net loss of $52M. It cut 2026 revenue guidance to $3.54B-$3.57B and recorded $134.9M in goodwill and intangible impairments. Bruker expanded its AI lab collaboration with Atinary, including a minority stake, to build AI-driven Self-Driving Labs using Chemspeed, FT-NMR and SciY software.
6 min readBruker Corporation (BRKR) said its board declared a quarterly cash dividend of $0.05 per common share ($0.01 par). The dividend was declared Aug. 14, 2026, with a record date of Sept. 21, 2026 and a payment date of Oct. 7, 2026, for shareholders of record then.
2 min readBruker (BRKR) reported Q2 2026 revenue of $838.5 million, up 5.2% year over year, with organic growth of 2.8% (3.4% excluding U.S. tariff refund impacts). Non-GAAP gross margin was 52.1% and non-GAAP EPS $0.49. FY2026 guidance: revenue $3.54B to $3.57B and non-GAAP EPS $2.10 to $2.15.
6 min readBruker (Nasdaq: BRKR) announced an expanded strategic collaboration with Atinary Technologies to integrate Atinary’s SDLabs self-driving lab platform with Chemspeed automation, Bruker instruments, and SciY software for closed-loop, agentic AI-driven R&D. Bruker also made a minority investment in Atinary; financial terms were not disclosed.
3 min readBruker reported Q2 revenue of $838.5M vs $854.8M estimates and adjusted EPS of $0.49 vs $0.38, with management citing weak U.S. academic and government funding and deep-tech delivery timing delays. It cut full-year revenue guidance to $3.56B midpoint and reiterated adjusted EPS of $2.13. Margin was -7.8%.
6 min readSimply Wall St reports Bruker (BRKR) drew investor attention after Q2 results showed rising sales but a net loss tied largely to impairment charges. The article cites 2026 revenue guidance, a 25.91% 90-day share return, and a consensus fair value of $59.75 versus a $56.32 close, with analyst targets ranging from $40 to $70.
3 min readBruker (NASDAQ:BRKR) reported Q2 2026 revenue of $838.5M, up 5.2% (organic growth 2.8%). Scientific Instruments bookings rose 10% organically with a book-to-bill above 1.0x. Non-GAAP EPS increased to $0.49; GAAP results included a non-cash goodwill impairment. Bruker kept 2026 non-GAAP EPS guidance at $2.10-$2.15 and updated revenue guidance to $3.54B-$3.57B for currency and tax effects.
6 min readUS stock indices rose to record highs as investors weighed strong Q2 tech earnings expectations. Bloomberg Intelligence projects Q2 earnings up about 23% for S&P 500, with 86% of 322 reporters beating estimates. Markets priced a 59% chance of a 25 bp Fed hike and 85% for an ECB hike. SOX and AI chip stocks led; oil fell and energy stocks lagged.
6 min readThe S&P 500 hit a new record high as Q2 earnings expectations rose. Bloomberg Intelligence projects Q2 earnings up about 23%, near Q1’s 30% surge. AI spending is expected to drive nearly 60% of S&P 500 EPS growth. So far, 86% of 322 companies beat estimates, per Bloomberg. Rate-hike odds are also discussed.
7 min readBruker (BRKR) shares fell 17.7% after the company reported Q2 results. Adjusted EPS of $0.49 beat estimates, but revenue was $838.5 million, below expectations. Bruker also cut full-year revenue guidance to a $3.56 billion midpoint, below analysts’ forecasts, driving the selloff despite the earnings beat.
3 min read
